115853-72-0 Usage
Description
2',6'-DiMethylcarbonylphenyl 9-Acridinecarboxylate 4'-NHS Ester is an organic compound that serves as an intermediate in the synthesis of luminescent agents. It is characterized by its off-white to pale yellow solid appearance and is known for its chemical properties that make it a valuable component in the development of various applications.
Uses
Used in Chemical Synthesis Industry:
2',6'-DiMethylcarbonylphenyl 9-Acridinecarboxylate 4'-NHS Ester is used as an intermediate for the synthesis of luminescent agents. Its role in this application is crucial due to its chemical properties that facilitate the creation of compounds with unique light-emitting characteristics, which can be utilized in various fields such as biotechnology, materials science, and pharmaceuticals.
Used in Biotechnology:
In the biotechnology industry, 2',6'-DiMethylcarbonylphenyl 9-Acridinecarboxylate 4'-NHS Ester is used as a component in the development of luminescent markers and probes. These markers and probes are essential tools for various research applications, including gene expression analysis, protein-protein interactions, and cellular imaging, due to their ability to emit light upon specific interactions or under certain conditions.
Used in Materials Science:
Within the materials science field, 2',6'-DiMethylcarbonylphenyl 9-Acridinecarboxylate 4'-NHS Ester is used as a key component in the synthesis of advanced luminescent materials. These materials have potential applications in the development of light-emitting diodes (LED), organic light-emitting diode (OLED) displays, and other optoelectronic devices, where their unique light-emitting properties can be harnessed for improved performance and energy efficiency.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2',6'-DiMethylcarbonylphenyl 9-Acridinecarboxylate 4'-NHS Ester is utilized as a building block for the development of novel luminescent drugs and drug delivery systems. Its incorporation into these systems can enhance the ability to track and monitor drug distribution, release, and interaction with target cells or tissues, ultimately leading to more effective and targeted therapeutic interventions.
Check Digit Verification of cas no
The CAS Registry Mumber 115853-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,8,5 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 115853-72:
(8*1)+(7*1)+(6*5)+(5*8)+(4*5)+(3*3)+(2*7)+(1*2)=130
130 % 10 = 0
So 115853-72-0 is a valid CAS Registry Number.
115853-72-0Relevant articles and documents
Synthesis of acridinium ester chemiluminescent substrate DMAE.NHS
-
, (2017/08/29)
The invention aims to provide a synthesis method of a chemiluminescent substrate namely acridinium ester 9-((4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)-2,6-dimethylphenoxyl)carbonyl)-10-methyl acridine onium methyl sulfate (DAME.NHS). The chemical structure of DMAE.NHS is represented in the description. According to the synthesis method, 3,5-dimethyl-4-hydroxyl benzoic acid, N-hydroxyl succinimide, and acridine-9-carbonyl chloride are taken as the raw materials, and after two steps of esterification reactions, the reaction product is subjected to methylation to obtain the target compound. Compared with other synthesis method, the provided synthesis method has the advantages that the steps are few, the method does not need any pricy reagent or solvent, the reaction conditions are mild, the product yield and purity are high, and the synthesis method is suitable for massive production.
